CLINICAL EVIDENCE
Evidence generation, presented with discipline.
Evidence generation, presented with discipline.
Evidence generation, presented with discipline.
FEATURED PUBLICATION / RANDOMISED CONTROLLED TRIAL / 2026
Topical Probiotics in Soybean Concentrate for Diabetic Foot Ulcers: A Randomised Controlled Trial
Topical Probiotics in Soybean Concentrate for Diabetic Foot Ulcers: A Randomised Controlled Trial
Hsu H, Yang C-C, Huang S-M, Wu M-S, Yao H-E, Lin Y-W. British Journal of Dermatology. 2026;194(6):1192–1194.
Hsu H, Yang C-C, Huang S-M, Wu M-S, Yao H-E, Lin Y-W. British Journal of Dermatology. 2026;194(6):1192–1194.
LACTERA’s clinical-development strategy combines real-world evidence, investigator experience, patient-outcome assessment and focused research collaboration. The 2026 BJD randomised controlled trial complements the earlier multicentre study published in Journal of Wound Care in 2023.
The primary publications remain the authoritative sources for study methodology, patient population, intervention and comparator protocols, endpoint definitions, safety reporting, statistical analysis and clinical interpretation.
LACTERA’s clinical-development strategy combines real-world evidence, investigator experience, patient-outcome assessment and focused research collaboration. The 2026 BJD randomised controlled trial complements the earlier multicentre study published in Journal of Wound Care in 2023.
The primary publications remain the authoritative sources for study methodology, patient population, intervention and comparator protocols, endpoint definitions, safety reporting, statistical analysis and clinical interpretation.